Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 77 entries
Sorted by: Best Match Show Resources per page
Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer.

Preventive medicine

Broutet N, Jeronimo J, Kumar S, Almonte M, Murillo R, Huy NVQ, Denny L, Kapambwe S, Bhatla N, Sebitloane M, Zhao F, Gravitt P, Adsul P, Rangaraj A, Dalal S, Newman M, Chowdhury R, Church K, Nakisige C, Diop M, Parham G, Thomson KA, Basu P, Steyn P.
PMID: 34896155
Prev Med. 2021 Dec 08;155:106906. doi: 10.1016/j.ypmed.2021.106906. Epub 2021 Dec 08.

BACKGROUND: Cervical cancer is a significant public health problem, with 570,000 new cases and 300,000 deaths of women per year globally, mostly in low- and middle-income countries. In 2018 the WHO Director General made a call to action for...

Cite
Broutet N, Jeronimo J, Kumar S, et al. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021;155:106906doi: 10.1016/j.ypmed.2021.106906.
Broutet, N., Jeronimo, J., Kumar, S., Almonte, M., Murillo, R., Huy, N. V. Q., Denny, L., Kapambwe, S., Bhatla, N., Sebitloane, M., Zhao, F., Gravitt, P., Adsul, P., Rangaraj, A., Dalal, S., Newman, M., Chowdhury, R., Church, K., Nakisige, C., Diop, M., Parham, G., Thomson, K. A., Basu, P., & Steyn, P. (2021). Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Preventive medicine, 155106906. https://doi.org/10.1016/j.ypmed.2021.106906
Broutet, Nathalie, et al. "Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer." Preventive medicine vol. 155 (2021): 106906. doi: https://doi.org/10.1016/j.ypmed.2021.106906
Broutet N, Jeronimo J, Kumar S, Almonte M, Murillo R, Huy NVQ, Denny L, Kapambwe S, Bhatla N, Sebitloane M, Zhao F, Gravitt P, Adsul P, Rangaraj A, Dalal S, Newman M, Chowdhury R, Church K, Nakisige C, Diop M, Parham G, Thomson KA, Basu P, Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021 Dec 08;155:106906. doi: 10.1016/j.ypmed.2021.106906. Epub 2021 Dec 08. PMID: 34896155.
Copy Download .nbib Format: NLM
Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy.

Indian journal of clinical biochemistry : IJCB

Singh B, Panda S, Nanda R, Pati S, Mangaraj M, Sahu PK, Mohapatra PC.
PMID: 21966106
Indian J Clin Biochem. 2010 Oct;25(4):367-70. doi: 10.1007/s12291-010-0090-2. Epub 2010 Nov 19.

Insulin resistance and the resultant hyperinsulinemia exacerbate the reproductive abnormalities of Polycystic Ovarian Syndrome by increasing ovarian androgen productions and decreasing serum sex hormone binding globulin. The present study was conducted to estimate serum insulin and testosterone level in...

Cite
Singh B, Panda S, Nanda R, et al. Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy. Indian J Clin Biochem. 2010;25(4):367-70doi: 10.1007/s12291-010-0090-2.
Singh, B., Panda, S., Nanda, R., Pati, S., Mangaraj, M., Sahu, P. K., & Mohapatra, P. C. (2010). Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy. Indian journal of clinical biochemistry : IJCB, 25(4), 367-70. https://doi.org/10.1007/s12291-010-0090-2
Singh, Bratati, et al. "Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy." Indian journal of clinical biochemistry : IJCB vol. 25,4 (2010): 367-70. doi: https://doi.org/10.1007/s12291-010-0090-2
Singh B, Panda S, Nanda R, Pati S, Mangaraj M, Sahu PK, Mohapatra PC. Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy. Indian J Clin Biochem. 2010 Oct;25(4):367-70. doi: 10.1007/s12291-010-0090-2. Epub 2010 Nov 19. PMID: 21966106; PMCID: PMC2994574.
Copy Download .nbib Format: NLM
'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus.

Rheumatology (Oxford, England)

Smith EMD, Gorst SL, Al-Abadi E, Hawley DP, Leone V, Pilkington C, Ramanan AV, Rangaraj S, Sridhar A, Beresford MW, Young B.
PMID: 33629109
Rheumatology (Oxford). 2021 Dec 01;60(12):5630-5641. doi: 10.1093/rheumatology/keab173.

OBJECTIVE: We sought to explore patient and parental views on treatment targets, outcome measures and study designs being considered for a future JSLE treat-to-target (T2T) study.METHODS: We conducted topic-guided, semistructured interviews with JSLE patients and parents and analysed the...

Cite
Smith EMD, Gorst SL, Al-Abadi E, et al. 'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus. Rheumatology (Oxford). 2021;60(12):5630-5641doi: 10.1093/rheumatology/keab173.
Smith, E. M. D., Gorst, S. L., Al-Abadi, E., Hawley, D. P., Leone, V., Pilkington, C., Ramanan, A. V., Rangaraj, S., Sridhar, A., Beresford, M. W., & Young, B. (2021). 'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus. Rheumatology (Oxford, England), 60(12), 5630-5641. https://doi.org/10.1093/rheumatology/keab173
Smith, Eve M D, et al. "'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus." Rheumatology (Oxford, England) vol. 60,12 (2021): 5630-5641. doi: https://doi.org/10.1093/rheumatology/keab173
Smith EMD, Gorst SL, Al-Abadi E, Hawley DP, Leone V, Pilkington C, Ramanan AV, Rangaraj S, Sridhar A, Beresford MW, Young B. 'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus. Rheumatology (Oxford). 2021 Dec 01;60(12):5630-5641. doi: 10.1093/rheumatology/keab173. PMID: 33629109; PMCID: PMC8645274.
Copy Download .nbib Format: NLM
Estimating the Risk of Chemotherapy Toxicity in Indian Geriatric Patient Population and Utility of Chemotherapy Risk Assessment Scale for High Age Patients (CRASH) Score.

South Asian journal of cancer

Mittal A, Rangaraju RR, Agarwal A, Chandragouda D, Batra S, Qureshi S.
PMID: 34938678
South Asian J Cancer. 2021 Sep 04;10(3):161-166. doi: 10.1055/s-0041-1729447. eCollection 2021 Sep.

No abstract available.

Cite
Mittal A, Rangaraju RR, Agarwal A, et al. Estimating the Risk of Chemotherapy Toxicity in Indian Geriatric Patient Population and Utility of Chemotherapy Risk Assessment Scale for High Age Patients (CRASH) Score. South Asian J Cancer. 2021;10(3):161-166doi: 10.1055/s-0041-1729447.
Mittal, A., Rangaraju, R. R., Agarwal, A., Chandragouda, D., Batra, S., & Qureshi, S. (2021). Estimating the Risk of Chemotherapy Toxicity in Indian Geriatric Patient Population and Utility of Chemotherapy Risk Assessment Scale for High Age Patients (CRASH) Score. South Asian journal of cancer, 10(3), 161-166. https://doi.org/10.1055/s-0041-1729447
Mittal, Aditi, et al. "Estimating the Risk of Chemotherapy Toxicity in Indian Geriatric Patient Population and Utility of Chemotherapy Risk Assessment Scale for High Age Patients (CRASH) Score." South Asian journal of cancer vol. 10,3 (2021): 161-166. doi: https://doi.org/10.1055/s-0041-1729447
Mittal A, Rangaraju RR, Agarwal A, Chandragouda D, Batra S, Qureshi S. Estimating the Risk of Chemotherapy Toxicity in Indian Geriatric Patient Population and Utility of Chemotherapy Risk Assessment Scale for High Age Patients (CRASH) Score. South Asian J Cancer. 2021 Sep 04;10(3):161-166. doi: 10.1055/s-0041-1729447. eCollection 2021 Sep. PMID: 34938678; PMCID: PMC8687865.
Copy Download .nbib Format: NLM
Evaluation of Serum Ferritin and Anti-Thyroid Peroxidase Antibody Status in Newly Diagnosed Subclinical Cases of Hypothyroidism.

Endocrine, metabolic & immune disorders drug targets

Tiwari R, Saharia GK, Mangaraj M.
PMID: 32981513
Endocr Metab Immune Disord Drug Targets. 2021;21(8):1453-1458. doi: 10.2174/1871530320666200925125404.

BACKGROUND: Serum ferritin concentrations are altered in hypothyroidism, but there is no available literature regarding the status of serum ferritin in anti-thyroid peroxidase (anti-TPO) positive hypothyroidism. The objectives of our study were to evaluate the titer of anti-TPO and...

Cite
Tiwari R, Saharia GK, Mangaraj M. Evaluation of Serum Ferritin and Anti-Thyroid Peroxidase Antibody Status in Newly Diagnosed Subclinical Cases of Hypothyroidism. Endocr Metab Immune Disord Drug Targets. 2021;21(8):1453-1458doi: 10.2174/1871530320666200925125404.
Tiwari, R., Saharia, G. K., & Mangaraj, M. (2021). Evaluation of Serum Ferritin and Anti-Thyroid Peroxidase Antibody Status in Newly Diagnosed Subclinical Cases of Hypothyroidism. Endocrine, metabolic & immune disorders drug targets, 21(8), 1453-1458. https://doi.org/10.2174/1871530320666200925125404
Tiwari, Rajlaxmi, et al. "Evaluation of Serum Ferritin and Anti-Thyroid Peroxidase Antibody Status in Newly Diagnosed Subclinical Cases of Hypothyroidism." Endocrine, metabolic & immune disorders drug targets vol. 21,8 (2021): 1453-1458. doi: https://doi.org/10.2174/1871530320666200925125404
Tiwari R, Saharia GK, Mangaraj M. Evaluation of Serum Ferritin and Anti-Thyroid Peroxidase Antibody Status in Newly Diagnosed Subclinical Cases of Hypothyroidism. Endocr Metab Immune Disord Drug Targets. 2021;21(8):1453-1458. doi: 10.2174/1871530320666200925125404. PMID: 32981513.
Copy Download .nbib Format: NLM
Influence of Surface States on the Optical and Cellular Property of Thermally Stable Red Emissive Graphitic Carbon Dots.

ACS applied bio materials

Singh B, Bahadur R, Rangara M, Gandhi MN, Srivastava R.
PMID: 35006801
ACS Appl Bio Mater. 2021 May 17;4(5):4641-4651. doi: 10.1021/acsabm.1c00379. Epub 2021 Apr 29.

Red emissive carbon dots from sucrose (SCD) were synthesized using a facile, isolation-free, one-pot method

Cite
Singh B, Bahadur R, Rangara M, et al. Influence of Surface States on the Optical and Cellular Property of Thermally Stable Red Emissive Graphitic Carbon Dots. ACS Appl Bio Mater. 2021;4(5):4641-4651doi: 10.1021/acsabm.1c00379.
Singh, B., Bahadur, R., Rangara, M., Gandhi, M. N., & Srivastava, R. (2021). Influence of Surface States on the Optical and Cellular Property of Thermally Stable Red Emissive Graphitic Carbon Dots. ACS applied bio materials, 4(5), 4641-4651. https://doi.org/10.1021/acsabm.1c00379
Singh, Barkha, et al. "Influence of Surface States on the Optical and Cellular Property of Thermally Stable Red Emissive Graphitic Carbon Dots." ACS applied bio materials vol. 4,5 (2021): 4641-4651. doi: https://doi.org/10.1021/acsabm.1c00379
Singh B, Bahadur R, Rangara M, Gandhi MN, Srivastava R. Influence of Surface States on the Optical and Cellular Property of Thermally Stable Red Emissive Graphitic Carbon Dots. ACS Appl Bio Mater. 2021 May 17;4(5):4641-4651. doi: 10.1021/acsabm.1c00379. Epub 2021 Apr 29. PMID: 35006801.
Copy Download .nbib Format: NLM
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study.

Rheumatology (Oxford, England)

Smith EMD, Rasul S, Ciurtin C, Al-Abadi E, Armon K, Bailey K, Brennan M, Gardner-Medwin J, Haslam K, Hawley DP, Lane S, Leahy A, Leone V, Malik G, Mewar D, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Sen E, Sridhar A, Wilkinson N, Beresford MW, McCann LJ, Hedrich CM.
PMID: 33690793
Rheumatology (Oxford). 2021 Nov 03;60(11):5271-5281. doi: 10.1093/rheumatology/keab210.

OBJECTIVES: This study aimed to test the performance of the new ACR and EULAR criteria, that include ANA positivity as entry criterion, in JSLE.METHODS: Performance of the ACR/EULAR-2019 criteria were compared with Systemic Lupus International Collaborating Clinics (SLICC-2012), using...

Cite
Smith EMD, Rasul S, Ciurtin C, et al. Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. Rheumatology (Oxford). 2021;60(11):5271-5281doi: 10.1093/rheumatology/keab210.
Smith, E. M. D., Rasul, S., Ciurtin, C., Al-Abadi, E., Armon, K., Bailey, K., Brennan, M., Gardner-Medwin, J., Haslam, K., Hawley, D. P., Lane, S., Leahy, A., Leone, V., Malik, G., Mewar, D., Moots, R., Pilkington, C., Ramanan, A. V., Rangaraj, S., Ratcliffe, A., Riley, P., Sen, E., Sridhar, A., Wilkinson, N., Beresford, M. W., McCann, L. J., & Hedrich, C. M. (2021). Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. Rheumatology (Oxford, England), 60(11), 5271-5281. https://doi.org/10.1093/rheumatology/keab210
Smith, Eve M D, et al. "Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study." Rheumatology (Oxford, England) vol. 60,11 (2021): 5271-5281. doi: https://doi.org/10.1093/rheumatology/keab210
Smith EMD, Rasul S, Ciurtin C, Al-Abadi E, Armon K, Bailey K, Brennan M, Gardner-Medwin J, Haslam K, Hawley DP, Lane S, Leahy A, Leone V, Malik G, Mewar D, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Sen E, Sridhar A, Wilkinson N, Beresford MW, McCann LJ, Hedrich CM. Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. Rheumatology (Oxford). 2021 Nov 03;60(11):5271-5281. doi: 10.1093/rheumatology/keab210. PMID: 33690793; PMCID: PMC8566265.
Copy Download .nbib Format: NLM
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.

Arthritis & rheumatology (Hoboken, N.J.)

Brogan P, Yeung RSM, Cleary G, Rangaraj S, Kasapcopur O, Hersh AO, Li S, Paripovic D, Schikler K, Zeft A, Bracaglia C, Eleftheriou D, Pordeli P, Melega S, Jamois C, Gaudreault J, Michalska M, Brunetta P, Cooper JC, Lehane PB.
PMID: 34164952
Arthritis Rheumatol. 2022 Jan;74(1):124-133. doi: 10.1002/art.41901. Epub 2021 Dec 05.

OBJECTIVE: To assess the safety, tolerability, pharmacokinetics, and efficacy of rituximab (RTX) in pediatric patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).METHODS: The Pediatric Polyangiitis Rituximab Study was a phase IIa, international, open-label, single-arm study. During the...

Cite
Brogan P, Yeung RSM, Cleary G, et al. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis. Arthritis Rheumatol. 2021;74(1):124-133doi: 10.1002/art.41901.
Brogan, P., Yeung, R. S. M., Cleary, G., Rangaraj, S., Kasapcopur, O., Hersh, A. O., Li, S., Paripovic, D., Schikler, K., Zeft, A., Bracaglia, C., Eleftheriou, D., Pordeli, P., Melega, S., Jamois, C., Gaudreault, J., Michalska, M., Brunetta, P., Cooper, J. C., Lehane, P. B. (2022). Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis. Arthritis & rheumatology (Hoboken, N.J.), 74(1), 124-133. https://doi.org/10.1002/art.41901
Brogan, Paul, et al. "Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis." Arthritis & rheumatology (Hoboken, N.J.) vol. 74,1 (2022): 124-133. doi: https://doi.org/10.1002/art.41901
Brogan P, Yeung RSM, Cleary G, Rangaraj S, Kasapcopur O, Hersh AO, Li S, Paripovic D, Schikler K, Zeft A, Bracaglia C, Eleftheriou D, Pordeli P, Melega S, Jamois C, Gaudreault J, Michalska M, Brunetta P, Cooper JC, Lehane PB. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis. Arthritis Rheumatol. 2022 Jan;74(1):124-133. doi: 10.1002/art.41901. Epub 2021 Dec 05. PMID: 34164952.
Copy Download .nbib Format: NLM
Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal.

Current research in pharmacology and drug discovery

Bhat A, Dalvi H, Jain H, Rangaraj N, Singh SB, Srivastava S.
PMID: 34909647
Curr Res Pharmacol Drug Discov. 2020 Dec 31;2:100012. doi: 10.1016/j.crphar.2020.100012. eCollection 2021.

Neurodegenerative disorders which affects a larger population pose a great clinical challenge. These disorders impact the quality of life of an individual by damaging the neurons, which are the unit cells of the brain. Clinicians are faced with the...

Cite
Bhat A, Dalvi H, Jain H, et al. Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal. Curr Res Pharmacol Drug Discov. 2020;2:100012doi: 10.1016/j.crphar.2020.100012.
Bhat, A., Dalvi, H., Jain, H., Rangaraj, N., Singh, S. B., & Srivastava, S. (2021). Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal. Current research in pharmacology and drug discovery, 2100012. https://doi.org/10.1016/j.crphar.2020.100012
Bhat, Aditi, et al. "Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal." Current research in pharmacology and drug discovery vol. 2 (2021): 100012. doi: https://doi.org/10.1016/j.crphar.2020.100012
Bhat A, Dalvi H, Jain H, Rangaraj N, Singh SB, Srivastava S. Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal. Curr Res Pharmacol Drug Discov. 2020 Dec 31;2:100012. doi: 10.1016/j.crphar.2020.100012. eCollection 2021. PMID: 34909647; PMCID: PMC8663947.
Copy Download .nbib Format: NLM
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study.

Lupus

Giani T, Smith EM, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Pregnolato F, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Cimaz R, Beresford MW, Hedrich CM.
PMID: 34601989
Lupus. 2021 Oct;30(12):1955-1965. doi: 10.1177/09612033211045050. Epub 2021 Oct 02.

INTRODUCTION: Juvenile-onset systemic lupus erythematosus (JSLE) is a rare autoimmune/inflammatory disease with significant morbidity and mortality. Neuropsychiatric (NP) involvement is a severe complication, encompassing a heterogeneous range of neurological and psychiatric manifestations.METHODS: Demographic, clinical, and laboratory features of NP-SLE...

Cite
Giani T, Smith EM, Al-Abadi E, et al. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. Lupus. 2021;30(12):1955-1965doi: 10.1177/09612033211045050.
Giani, T., Smith, E. M., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., Davidson, J., Gardner-Medwin, J., Haslam, K., Hawley, D. P., Leahy, A., Leone, V., McErlane, F., Mewar, D., Modgil, G., Moots, R., Pilkington, C., Pregnolato, F., Ramanan, A. V., Rangaraj, S., Riley, P., Sridhar, A., Wilkinson, N., Cimaz, R., Beresford, M. W., Hedrich, C. M. (2021). Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. Lupus, 30(12), 1955-1965. https://doi.org/10.1177/09612033211045050
Giani, Teresa, et al. "Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study." Lupus vol. 30,12 (2021): 1955-1965. doi: https://doi.org/10.1177/09612033211045050
Giani T, Smith EM, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Pregnolato F, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Cimaz R, Beresford MW, Hedrich CM. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. Lupus. 2021 Oct;30(12):1955-1965. doi: 10.1177/09612033211045050. Epub 2021 Oct 02. PMID: 34601989; PMCID: PMC8649437.
Copy Download .nbib Format: NLM
Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer.

Preventive medicine

Broutet N, Jeronimo J, Kumar S, Almonte M, Murillo R, Huy NVQ, Denny L, Kapambwe S, Bhatla N, Sebitloane M, Zhao F, Gravitt P, Adsul P, Rangaraj A, Dalal S, Newman M, Chowdhury R, Church K, Nakisige C, Diop M, Parham G, Thomson KA, Basu P, Steyn P.
PMID: 34896155
Prev Med. 2021 Dec 08;106906. doi: 10.1016/j.ypmed.2021.106906. Epub 2021 Dec 08.

BACKGROUND: Cervical cancer is a significant public health problem, with 570,000 new cases and 300,000 deaths of women per year globally, mostly in low- and middle-income countries. In 2018 the WHO Director General made a call to action for...

Cite
Broutet N, Jeronimo J, Kumar S, et al. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021;106906doi: 10.1016/j.ypmed.2021.106906.
Broutet, N., Jeronimo, J., Kumar, S., Almonte, M., Murillo, R., Huy, N. V. Q., Denny, L., Kapambwe, S., Bhatla, N., Sebitloane, M., Zhao, F., Gravitt, P., Adsul, P., Rangaraj, A., Dalal, S., Newman, M., Chowdhury, R., Church, K., Nakisige, C., Diop, M., Parham, G., Thomson, K. A., Basu, P., & Steyn, P. (2021). Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Preventive medicine, 106906. https://doi.org/10.1016/j.ypmed.2021.106906
Broutet, Nathalie, et al. "Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer." Preventive medicine vol. (2021): 106906. doi: https://doi.org/10.1016/j.ypmed.2021.106906
Broutet N, Jeronimo J, Kumar S, Almonte M, Murillo R, Huy NVQ, Denny L, Kapambwe S, Bhatla N, Sebitloane M, Zhao F, Gravitt P, Adsul P, Rangaraj A, Dalal S, Newman M, Chowdhury R, Church K, Nakisige C, Diop M, Parham G, Thomson KA, Basu P, Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2021 Dec 08;106906. doi: 10.1016/j.ypmed.2021.106906. Epub 2021 Dec 08. PMID: 34896155.
Copy Download .nbib Format: NLM
Lower respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Rubinstein E, Carbon C, Rangaraj M, Ignacio Santos J, Thys JP, Veyssier P.
PMID: 11869253
Clin Microbiol Infect. 1998 Apr;4:S42-S50.

No abstract available.

Cite
Rubinstein E, Carbon C, Rangaraj M, et al. Lower respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones. Clin Microbiol Infect. 1998;4:S42-S50
Rubinstein, E., Carbon, C., Rangaraj, M., Ignacio Santos, J., Thys, J. P., & Veyssier, P. (1998). Lower respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 4S42-S50.
Rubinstein, Ethan, et al. "Lower respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 4 (1998): S42-S50.
Rubinstein E, Carbon C, Rangaraj M, Ignacio Santos J, Thys JP, Veyssier P. Lower respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones. Clin Microbiol Infect. 1998 Apr;4:S42-S50. PMID: 11869253.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 77 entries